Stephanie Michael Delvo, MD - Medicare Obstetrics/gynecology in Bismarck, ND

Stephanie Michael Delvo, MD is a medicare enrolled "Obstetrics & Gynecology" physician in Bismarck, North Dakota. She went to University Of North Dakota School Of Medicine and graduated in 2013 and has 11 years of diverse experience with area of expertise as Obstetrics/gynecology. She is a member of the group practice Innovis Health Llc and her current practice location is 401 N 9th St, Bismarck, North Dakota. You can reach out to her office (for appointments etc.) via phone at (701) 530-6000.

Stephanie Michael Delvo is licensed to practice in North Dakota (license number 12952) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1336377357.

Contact Information

Stephanie Michael Delvo, MD
401 N 9th St,
Bismarck, ND 58501-4530
(701) 530-6000
(701) 530-6407



Physician's Profile

Full NameStephanie Michael Delvo
GenderFemale
SpecialityObstetrics/gynecology
Experience11 Years
Location401 N 9th St, Bismarck, North Dakota
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Stephanie Michael Delvo attended and graduated from University Of North Dakota School Of Medicine in 2013
  NPI Data:
  • NPI Number: 1336377357
  • Provider Enumeration Date: 06/29/2009
  • Last Update Date: 11/12/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 6002044278
  • Enrollment ID: I20140115000340

Medical Identifiers

Medical identifiers for Stephanie Michael Delvo such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1336377357NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207V00000XObstetrics & Gynecology 12952 (North Dakota)Primary
390200000XStudent In An Organized Health Care Education/training Program (* (Not Available))Secondary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Innovis Health Llc9931298155473

News Archive

Hot flashes underreported and linked to forgetfulness

Women in midlife underreport the number of hot flashes that they experience by more than 40 percent, and these hot flashes are linked to poor verbal memory, according to a study by researchers at the University of Illinois at Chicago.

Transcranial magnetic stimulation effective in treating major depression

Researchers at the University of Pennsylvania School of Medicine and other study sites have found that transcranial magnetic stimulation (TMS) – a non-invasive technique that excites neurons in the brain via magnetic pulses passed through the scalp – is a safe and effective, non-drug treatment with minimal side effects for patients with major depression who have tried other treatment options without benefit.

Multiple tattoos increase risk of contracting hepatitis C: Study

Youth, prison inmates and individuals with multiple tattoos that cover large parts of their bodies are at higher risk of contracting hepatitis C and other blood-borne diseases, according to a University of British Columbia study.The researchers reviewed and analysed 124 studies from 30 countries, including Canada, Iran, Italy, Brazil and the United States, and found the incidence of hepatitis C after tattooing is directly linked with the number of tattoos an individual receives. The findings are published in the current issue of the International Journal of Infectious Diseases.

New behavioral intervention program could help reduce HIV infection rates among Latino men

Men who have sex with men accounted for two thirds of all new HIV infections in the United States, with 26 percent occurring in Latinos, according to 2014 data. If those rates continue, it is estimated that one in four Latino MSM may be diagnosed with HIV during his lifetime.

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Stephanie Michael Delvo allows following entities to bill medicare on her behalf.
Entity NameMid Dakota Clinic, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1275587826
PECOS PAC ID: 9638072895
Enrollment ID: O20040127001063

News Archive

Hot flashes underreported and linked to forgetfulness

Women in midlife underreport the number of hot flashes that they experience by more than 40 percent, and these hot flashes are linked to poor verbal memory, according to a study by researchers at the University of Illinois at Chicago.

Transcranial magnetic stimulation effective in treating major depression

Researchers at the University of Pennsylvania School of Medicine and other study sites have found that transcranial magnetic stimulation (TMS) – a non-invasive technique that excites neurons in the brain via magnetic pulses passed through the scalp – is a safe and effective, non-drug treatment with minimal side effects for patients with major depression who have tried other treatment options without benefit.

Multiple tattoos increase risk of contracting hepatitis C: Study

Youth, prison inmates and individuals with multiple tattoos that cover large parts of their bodies are at higher risk of contracting hepatitis C and other blood-borne diseases, according to a University of British Columbia study.The researchers reviewed and analysed 124 studies from 30 countries, including Canada, Iran, Italy, Brazil and the United States, and found the incidence of hepatitis C after tattooing is directly linked with the number of tattoos an individual receives. The findings are published in the current issue of the International Journal of Infectious Diseases.

New behavioral intervention program could help reduce HIV infection rates among Latino men

Men who have sex with men accounted for two thirds of all new HIV infections in the United States, with 26 percent occurring in Latinos, according to 2014 data. If those rates continue, it is estimated that one in four Latino MSM may be diagnosed with HIV during his lifetime.

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.

Read more Medical News

› Verified 7 days ago

Entity NameInnovis Health Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1215125463
PECOS PAC ID: 9931298155
Enrollment ID: O20071211000158

News Archive

Hot flashes underreported and linked to forgetfulness

Women in midlife underreport the number of hot flashes that they experience by more than 40 percent, and these hot flashes are linked to poor verbal memory, according to a study by researchers at the University of Illinois at Chicago.

Transcranial magnetic stimulation effective in treating major depression

Researchers at the University of Pennsylvania School of Medicine and other study sites have found that transcranial magnetic stimulation (TMS) – a non-invasive technique that excites neurons in the brain via magnetic pulses passed through the scalp – is a safe and effective, non-drug treatment with minimal side effects for patients with major depression who have tried other treatment options without benefit.

Multiple tattoos increase risk of contracting hepatitis C: Study

Youth, prison inmates and individuals with multiple tattoos that cover large parts of their bodies are at higher risk of contracting hepatitis C and other blood-borne diseases, according to a University of British Columbia study.The researchers reviewed and analysed 124 studies from 30 countries, including Canada, Iran, Italy, Brazil and the United States, and found the incidence of hepatitis C after tattooing is directly linked with the number of tattoos an individual receives. The findings are published in the current issue of the International Journal of Infectious Diseases.

New behavioral intervention program could help reduce HIV infection rates among Latino men

Men who have sex with men accounted for two thirds of all new HIV infections in the United States, with 26 percent occurring in Latinos, according to 2014 data. If those rates continue, it is estimated that one in four Latino MSM may be diagnosed with HIV during his lifetime.

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Stephanie Michael Delvo is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Stephanie Michael Delvo, MD
401 N 9th St,
Bismarck, ND 58501-4530

Ph: (701) 530-6000
Stephanie Michael Delvo, MD
401 N 9th St,
Bismarck, ND 58501-4530

Ph: (701) 530-6000

News Archive

Hot flashes underreported and linked to forgetfulness

Women in midlife underreport the number of hot flashes that they experience by more than 40 percent, and these hot flashes are linked to poor verbal memory, according to a study by researchers at the University of Illinois at Chicago.

Transcranial magnetic stimulation effective in treating major depression

Researchers at the University of Pennsylvania School of Medicine and other study sites have found that transcranial magnetic stimulation (TMS) – a non-invasive technique that excites neurons in the brain via magnetic pulses passed through the scalp – is a safe and effective, non-drug treatment with minimal side effects for patients with major depression who have tried other treatment options without benefit.

Multiple tattoos increase risk of contracting hepatitis C: Study

Youth, prison inmates and individuals with multiple tattoos that cover large parts of their bodies are at higher risk of contracting hepatitis C and other blood-borne diseases, according to a University of British Columbia study.The researchers reviewed and analysed 124 studies from 30 countries, including Canada, Iran, Italy, Brazil and the United States, and found the incidence of hepatitis C after tattooing is directly linked with the number of tattoos an individual receives. The findings are published in the current issue of the International Journal of Infectious Diseases.

New behavioral intervention program could help reduce HIV infection rates among Latino men

Men who have sex with men accounted for two thirds of all new HIV infections in the United States, with 26 percent occurring in Latinos, according to 2014 data. If those rates continue, it is estimated that one in four Latino MSM may be diagnosed with HIV during his lifetime.

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.

Read more News

› Verified 7 days ago


Obstetrics & Gynecology Doctors in Bismarck, ND

Rachel Marohl, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 1000 E Rosser Ave, Bismarck, ND 58501
Phone: 701-712-4500    
Dr. Jessica D Sedevie, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 414 N 7th St, Bismarck, ND 58501
Phone: 701-323-5441    
Dr. Jerry M Obritsch, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 1000 E Rosser Ave, Bismarck, ND 58501
Phone: 701-712-4500    Fax: 701-712-4098
Dr. Peter L Klemin, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 414 N. 7th St., Medcenter One, Inc., Bismarck, ND 58501
Phone: 701-323-5870    Fax: 701-323-5869
Peter A.u. Woodrow, MD
Obstetrics & Gynecology
Medicare: Not Enrolled in Medicare
Practice Location: 414 N 7th St, Bismarck, ND 58501
Phone: 701-323-6543    Fax: 701-323-5709
Laura Elizabeth Knutson, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 1000 E Rosser Ave, Bismarck, ND 58501
Phone: 701-712-4541    Fax: 701-712-4191
Dr. Shannon S Bradley, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 310 N 10th St, Bismarck, ND 58501
Phone: 701-530-6000    Fax: 701-530-6430

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.